Related Experiment Videos
Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity
E Marchioni1, E Perucca, D Soragna
1Institute of Neurology, University of Pavia, Pavia, Italy.
Neurology
|March 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy.
Journal of the neurological sciences·2021
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study.
European journal of neurology·2019
Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.
European journal of neurology·2019
Long-lasting and controlled antioxidant property of immobilized gold nanoparticles for intelligent packaging.
Colloids and surfaces. B, Biointerfaces·2019
Stroke-like events after brain radiotherapy: a large series with long-term follow-up.
European journal of neurology·2018
Right Brain: Language Without Speech.
Neurology·2026
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.
medRxiv : the preprint server for health sciences·2026
Mitochondrial rewiring supports survival of triple negative breast cancer cells after ionizing radiation.
bioRxiv : the preprint server for biology·2026
A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.
bioRxiv : the preprint server for biology·2026
Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.
bioRxiv : the preprint server for biology·2026
Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.
medRxiv : the preprint server for health sciences·2026